Live Interactive session December 12, 2020 at 15:00 JST (06:00 GMT)
Lectures and associated resources available December 12, 2020
Chaewon Shin and Beomseok Jeon
The main objective of this course is to provide an educational overview on the neuropathology of movement disorders.
This virtual course will discuss the major neurodegenerative pathologies including synucleinopathy, juvenile parkinsonism, tauopathy, and their mixed pathologies, and the pathologies of hyperkinetic movement disorders such as ataxia and dystonia. These topics will be presented in sessions of instructive lectures and clinico-pathologic case discussions.
The participants will learn principal knowledge and practice with the illustrative cases on the neuropathology of movement disorders.
Live Question and Answer
This course is intended for general neurologists, neurology residents, movement disorders specialists, neuropathologists, neurobiologists, and other researchers.
- To discuss the neuropathologies of major movement disorders
- To discuss the neuropathology of juvenile parkinsonism
- To discuss the neuropathologies of hyperkinetic movement disorders
- To discuss the clinico-pathologic correlations of movement disorders
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement:
The International Parkinson and Movement Disorder Society designates this activity for a maximum of 4.00 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation.
Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.
Content Validity Statement:
All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.
Disclosure of Financial Relationships:
All individuals in control of content for this webinar are required to disclose all relevant financial relationships with commercial interests as defined by the ACCME.